semaglutide risks Semaglutide: What we know about safety and cancer risk Semaglutide isn’t just a “weight-loss

The best alternatives to semaglutide for weight loss, including other medications and approaches

Contact your trial team or GP promptly if you experience: Persistent or severe nausea, vomiting, or diarrhoea that prevents adequate fluid or food intake Signs of dehydration, such as dizziness, dark urine, or reduced urination Severe or persistent abdominal pain, which may rarely indicate pancreatitis a known risk with GLP-1 receptor agonist therapies or gallbladder problems [18] [21] Rapid or irregular heartbeat (palpitations) Significant injection site reactions, including signs of infection (redness, warmth, swelling, or discharge) Symptoms of low blood sugar (hypoglycaemia) if you are also taking insulin or a sulfonylurea, such as shakiness, sweating, or confusion If you are unsure whether your symptoms require urgent attention, contact NHS 111 (by phone or online at 111.nhs.uk) for advice

It cites clinical trial data for its molecules (15 to 20% for semaglutide, 20 to 22% for tirzepatide from SURMOUNT-1 and STEP)

To verify your provider is operating legally, read our guide on compounded semaglutide safety

I felt like I finally had my life back, Khoury said

Instead of titrating up to a high therapeutic dose intended for weight loss, microdosing uses a much smaller amount, enough to help regulate appetite, insulin response, and metabolic efficiency without the intensity of full-dose treatment